基于Web的动态诺米图,用于预测心力衰竭死亡风险,轻微减少喷射分数
Wei Guo1, Jing Tian1, Yajing Wang1
1Department of Cardiology, the 1st Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, People's Republic of China.
Risk management and healthcare policy
|August 19, 2024
概括
一个新的动态名录,APSELNH,准确地预测心力衰竭的死亡风险轻微减少喷射分数 (HFmrEF) 患者使用N-终端亲B型尿素 (NT-proBNP) 和估计的膜过率 (eGFR). 这种工具有助于临床决策,以改善患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 医疗信息学 医疗信息学
- 预测模型的预测建模
背景情况:
- 轻微减少喷射分数 (HFmrEF) 的心力衰竭需要准确的预后工具.
- 现有的模型可能无法完全捕捉HFmrEF中所有原因死亡率的动态风险因素.
- N-终端亲B型尿素 (NT-proBNP) 和估计的膜过率 (eGFR) 是心力衰竭管理的关键生物标志物.
研究的目的:
- 开发和验证用于预测HFmrEF患者全因死亡率的整合性动态名谱.
- 将NT-proBNP和eGFR纳入名ogram中作为关键预测因素.
- 在HFmrEF中创建一个功能性临床决策支持工具,用于预后评估.
主要方法:
- 预计将招募790名HFmrEF患者用于模型开发.
- 使用LASSO回归和随机生存森林来进行预测器选择.
- 开发了一种使用Cox比例危险模型的动态名录,在内部 (Bootstrap) 和外部 (338名患者) 验证.
- 使用C指数,AUC,校准曲线和决策曲线分析 (DCA) 评估性能.
主要成果:
- 在APSELNH nomogram中确定了最佳预测因子,包括NT-proBNP和eGFR.
- 实现了高歧视性,C指数为0.858 (发展) 和0.826 (验证),AUC>0.8.8.
- 通过DCA和校准曲线证明了临床适用性和一致性.
- NT-proBNP和eGFR显著提高了名ogram的预测价值.
结论:
- 开发的动态APSELNH名图是HFmrEF的有效临床决策支持工具.
- 它提供了对所有死因死亡风险的准确预后评估.
- 该名录是可访问和功能,增强HFmrEF患者的临床管理.
更多相关视频
11:04Quantification of Global Diastolic Function by Kinematic Modeling-based Analysis of Transmitral Flow via the Parametrized Diastolic Filling Formalism
Published on: September 1, 2014
11.2K
07:49Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
1.3K
相关概念视频
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
405
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
405
Heart Failure Drugs: Diuretics
352
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
352
